ARTICLE | Distillery Therapeutics
Neurology
January 23, 2019 12:08 AM UTC
In vitro and mouse studies identified a quinoline-based GLO1 inhibitor that could help treat depression. In vitro screening of a library of metal-binding pharmacophores in an activity assay and optimi...
BCIQ Company Profiles
BCIQ Target Profiles